🏛️ Verified NIH Record • Updated 2024-10-30
Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders. (NCT04221997)
Extracellular Vesicles as Predictors of Antidepressant Outcomes in Pediatric Anxiety (EV-SOPRANO)
🟢 Recruiting Phase4 💊 Investigational Drug / Biologic Sponsor: University of Cincinnati
🩺 Plain-English Summary (8th-Grade Level)
A Multicenter, acute, randomized, double-blind, placebo-controlled, flexible-dose trial with the treatment of sertraline.
Who can join: Review the eligibility criteria below.
Location: University of Cincinnati — Cincinnati, Ohio
Age range: 8 Years to 17 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Cincinnati — Cincinnati, Ohio
📞 Contact the Study Coordinator
Phone: (513) 558-4422
Email: heysehk@uc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Anxiety Disorders
- Fluoxetine vs CBT in Childhood Anxiety Disorders — Los Angeles, California
- Pre-Post Intervention Study to Investigate the Safety, Feasibility, & Efficacy of the NeurGear ZenBud System for the Treatment of Anxiety & Anxiety-Related Symptoms — Rochester, New York
- Digital Coach to Support Exposure Therapy Homework for Anxious Youth — Belmont, Massachusetts
- MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients — Indianapolis, Indiana
- Connectomic Targeted TMS Target for Refractory Anxiety — Boston, Massachusetts
- Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population — Boston, Massachusetts
Explore by condition: All Anxiety Disorders clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.